Guanidine derivatives in medicine.
D000818:Animals; D001369:Axons / Q000187:drug effects; D001645:Biguanides / Q000494:pharmacology; D001665:Binding Sites; D001667:Binding, Competitive; D002118:Calcium / Q000378:metabolism; D002413:Cations, Divalent; D002414:Cations, Monovalent; D055598:Chemical Phenomena; D002621:Chemistry; D003864:Depression, Chemical; D004058:Diffusion; D005943:Gluconeogenesis / Q000187:drug effects; D006145:Guanethidine / Q000494:pharmacology; D006146:Guanidines / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents; D007328:Insulin / Q000502:physiology; D009411:Nerve Endings / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D011770:Pyruvate Kinase / Q000037:antagonists & inhibitors; D013329:Structure-Activity Relationship; D013565:Sympatholytics
D001645:Biguanides; D002413:Cations, Divalent; D002414:Cations, Monovalent; D006146:Guanidines; D007004:Hypoglycemic Agents; D007328:Insulin; D013565:Sympatholytics; D011770:Pyruvate Kinase; D002118:Calcium; D006145:Guanethidine